{
  "docId": "019de072-f883-7038-87b7-1190d38538fc",
  "docSlug": "b2613cd3e65595fa61ed3ce545efa4c9",
  "documentTitle": "Exscientia | Investor Presentation Deck | 37 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 37,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "problem_statement",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 10,
  "notes": "The slide uses a small multiples approach to show dose-response curves across different patient samples and time points, highlighting a clear stratification.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-f883-7038-87b7-1190d38538fc/24",
  "deckHref": "/decks/019de072-f883-7038-87b7-1190d38538fc",
  "deckJsonHref": "/decks/019de072-f883-7038-87b7-1190d38538fc.json",
  "deckAnchorHref": "/decks/019de072-f883-7038-87b7-1190d38538fc#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.15,
        "x": 0.82,
        "y": 0.23
      },
      "kind": "chart",
      "text": "Summary dot plots for Group I vs Group II at 24h, 48h, 72h",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d5746aa7-279f-45ec-874c-74317d775250",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.75,
        "x": 0.04,
        "y": 0.23
      },
      "kind": "chart",
      "text": "Small multiples of dose-response curves for 10 patient samples across 3 experiments",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b38d38b-d605-4240-9d42-689d79e78658",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.65,
        "x": 0.08,
        "y": 0.73
      },
      "kind": "paragraph",
      "text": "Group II (n=4) require higher concentrations of EXS617 than Group I (n=6) for effect. Understanding why will guide patient selection and is the focus of ongoing studies",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9463fb9-4396-4828-a40d-e109bb601798",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.65,
        "x": 0.08,
        "y": 0.13
      },
      "kind": "title",
      "text": "EXS617 (CDK7i): ovarian cancer patient samples stratify into two groups",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71232f82-9279-4902-97cd-51871eef6b00",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.08,
        "y": 0.06
      },
      "kind": "title",
      "text": "Defining patient selection during drug design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b1da8f3c-c410-44be-aa80-86076145c46f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "stratification-analysis",
      "slug": null,
      "matchId": "868e88a8-8e45-477b-b728-360cf4ff3eb7",
      "evidence": "Grouping patient samples by drug sensitivity",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 24,
      "from": 24,
      "beatId": "b1967336-687d-4250-84a6-afc8c6806660",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The deck presents a clear problem statement on slide 24",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 35,
      "from": 24,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5c4c8d7b-e37e-409f-8937-2163508fee37",
      "evidence": "The deck presents data on the consequences of traditional drug discovery methods on slides 24-35",
      "position": 0,
      "objective": "Highlight the consequences of not adopting Exscientia's AI-driven approach",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 37,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "7b15f9dd-8590-4693-8bcf-77e7f6a4d27a",
      "evidence": "The deck presents a clear narrative around Exscientia's strategy and its benefits throughout",
      "position": 1,
      "objective": "Explain Exscientia's patient-first AI strategy and its benefits",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}